CUVL · Clinuvel Pharmaceuticals Ltd · Documents
Market Cap
$262.03M
Shares
50.49M
Volume · Oct 20
3103
Avg daily vol (3M)
13.08K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | Clinuvel Pharmaceuticals Limited notified the Australian Securities Exchange of the cessation of securities through an Appendix 3H notification. | 2026-10-15 | — | |
| 6-K | — | 2026-10-07 | — | |
| 6-K | — | 2026-10-02 | — | |
| 6-K | — | 2026-10-01 | — | |
| 6-K | — | 2026-09-09 | 2026-09-08 | |
| 6-K | — | 2026-08-27 | — | |
| 6-K | — | 2026-08-20 | — | |
| 6-K | — | 2026-08-12 | — | |
| 6-K | — | 2026-07-30 | — | |
| 6-K | — | 2026-07-28 | — | |
| 6-K | — | 2026-07-27 | — | |
| 6-K | — | 2026-07-23 | — | |
| 6-K | — | 2026-07-22 | 2026-07-21 | |
| 6-K | — | 2026-07-22 | 2026-07-21 |
Showing 1–14 of 14 filings